# The Impact of Early Protocol Biopsy in Kidney Transplant

> **NCT02733510** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT02733510
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733510, "The Impact of Early Protocol Biopsy in Kidney Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02733510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*